A complete application in a minute
Tailored resume and cover letter, ready to send.
Oslo University Hospital offers a 3-year, 100% PhD position in the Department of Pediatric Research, Rikshospitalet. The project focuses on neonatal cholestasis using iPSC-derived liver organoids to study disease mechanisms and potential therapies.
The candidate will be supervised by Professor Runar Almaas and co-supervisor Barbora Smolkova, with work conducted in an international, collaborative environment; documentation and reporting in English or Scandinavian languages are required.
3-year 100% PhD position is available at the Department of Pediatric Research, OUS Rikshospitalet for a highly motivated and skilled PhD student on a project funded by South-Eastern Norway Regional Health Authority. The position is available from 23rd November 2026.
Neonatal cholestasis is a condition with impaired bile flow causing accumulation of bile acids and bilirubin, liver damage and debilitating pruritus. Reduction in bile to the intestine results in malabsorption, reduced weight gain, vitamin deficiency and changes in microbiota. Both genetic and environmental factors can result in cholestasis.
About the Department / Research Group
Professor Runar Almaas (Pediatric hepatology) at PFI, OUS is leading the project. The PhD candidate will be supervised by him and by Co-supervisor Barbora Smolkova (PhD) and senior researcher Gareth Sullivan. The group is using induced pluripotent stem cells for making liver organoids and a major part of the work will be related to this model.
What Tasks and Responsibilities Are Associated with the Position?
To reveal mechanisms of cholestasis and pruritus and to investigate novel potential treatments we are using liver organoids derived from disease-specific induced pluripotent stem cells. iPSC-derived liver organoids are a unique model that can mimic key features of the human liver and can be used to study liver development and disease. In these project liver organoids will be used for studying protein trafficking, effect of modulating factors and potential drugs.
Practical Information
We request that relevant documentation be attached to the application. Please note that all documents should be in English or a Scandinavian language.
Runar Almaas,Head of Department,+4741321932
Sognsvannsveien 20
0372Oslo
Arbeidsgiver: Oslo universitetssykehus HF
Referansenr.: 5194655530
Stillingsprosent: 100%
Contract
Startdato: 23.11.2026
Sluttdato: 09.11.2029
Søknadsfrist: 15.11.2026